[Federal Register Volume 64, Number 168 (Tuesday, August 31, 1999)]
[Notices]
[Pages 47507-47508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22525]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee, Subcommittee on Future
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on
Vaccine Safety and Communication Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 9 a.m.-2 p.m., September 16, 1999; 8:30 a.m.-
12:45 p.m., September 17, 1999.
Place: Hubert H. Humphrey Building, Room 505A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m.
Entrance to the meeting at other times during the day cannot be
assured.
Purpose: This committee advises and makes recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
Matters To Be Discussed: Agenda items will include: an update on
the National Vaccine Program Office (NVPO) activities; a workshop
report on thimerasol in vaccines; an update on rotavirus vaccine
recommendations; an update on the Vaccine Safety and Communication
Subcommittee; decision making and communication issues in vaccine
safety; an update on the immunization registries initiative; reports
from the Future Vaccines Subcommittee, Vaccine Safety and
Communication Subcommittee and the Immunization Coverage
Subcommittee; an update on pandemic preparedness planning; and
discussions on immunization challenges in Mexico and Canada.
Name: Subcommittee on Future Vaccines.
Time and Date: 2:45 p.m.-5 p.m., September 16, 1999.
Place: Hubert H. Humphrey Building, Room 305A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee develops policy options and guides
national activities that lead to accelerated development, licensure,
and the best use of new vaccines in the simplest possible
immunization schedules.
Matters To Be Discussed: Agenda items will include discussions
regarding the Institute of Medicine (IOM) report concerning
cytomegalovirus vaccines and the IOM report concerning enteric
bacteria vaccines.
Name: Subcommittee on Immunization Coverage.
Time and Date: 2:45 p.m.-5 p.m., September 16, 1999.
Place: Hubert H. Humphrey Building, Room 505A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will identify and propose solutions
that provide a multifaceted and holistic approach to reducing
barriers that result in low immunization coverage for children.
Matters To Be Discussed: Agenda items will include updates on
the roll out process for the ``Strategies to Sustain Success''
initiative; the status of the paper on adult immunizations at non-
traditional sites and standards for adult immunizations at non-
[[Page 47508]]
traditional sites; and, adolescent immunizations. The subcommittee
will also discuss revisions of adult immunization standards in
conjunction with the National Coalition for Adult Immunization; and
assessment of vaccine coverage in view of recent vaccine safety
issues.
Name: Subcommittee on Vaccine Safety and Communication.
Time and Date: 2:45 p.m.-5 p.m., September 16, 1999.
Place: Hubert H. Humphrey Building, Room 325A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee reviews issues relevant to vaccine
safety and adverse reactions to vaccines.
Matters To Be Discussed: Agenda items include a discussion on
Thimerosal in vaccines, rotavirus vaccine and intussusception and
the private governmental communications/response to acute vaccine
safety issues.
Agenda items are subject to change as priorities dictate.
CONTACT PERSON FOR MORE INFORMATION: Gloria Sagar, Committee Management
Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S A-11, Atlanta,
Georgia 30333, telephone 404/639-4450.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: August 24, 1999.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 99-22525 Filed 8-30-99; 8:45 am]
BILLING CODE 4163-18-P
